Episode Summary
This episode examines groundbreaking findings from the COSMOS randomized clinical trial investigating whether daily multivitamin–multimineral supplementation influences biological ageing. Using advanced epigenetic clocks that measure DNA methylation patterns, researchers evaluated the effects of nutritional interventions on epigenetic ageing markers in older adults. The study demonstrates that multivitamin supplementation produced modest but statistically significant slowing of second-generation epigenetic ageing markers over a two-year period, offering new insights into the relationship between nutritional interventions and biological ageing processes.
Key Topics Discussed
- Epigenetic clocks and biological age assessment using DNA methylation patterns
- COSMOS randomized clinical trial design and methodology for supplement efficacy evaluation
- Multivitamin–multimineral supplementation effects on aging biomarkers in older adults
- Cocoa extract supplementation outcomes and comparative supplement safety analysis
- Second-generation epigenetic ageing markers and clinical significance
- Long-term health outcomes and nutritional intervention strategies for healthy ageing
Key Takeaways
- Daily multivitamin–multimineral supplementation demonstrated measurable benefits on epigenetic ageing markers, suggesting potential biological mechanisms for healthy ageing
- The observed effect, while statistically significant, remained modest in magnitude, emphasizing the importance of realistic expectations regarding supplement interventions
- Cocoa extract supplementation showed no detectable effects on evaluated epigenetic ageing indicators in this population
- Rigorous randomized clinical trial methodology strengthens evidence for supplement safety and efficacy assessment in aging research
- Findings contribute to growing scientific literature on nutritional interventions as potential strategies for addressing biological ageing
About This Episode
Understanding how nutritional interventions affect biological ageing has significant implications for preventive medicine, clinical practice, and health policy. This episode addresses critical questions relevant to healthcare providers and older adult populations globally, including Georgia, where optimizing healthy ageing and long-term disease prevention are public health priorities. By evaluating evidence-based supplement research, clinicians can make informed recommendations regarding multivitamin use in aging populations. The COSMOS trial represents an important contribution to supplement research methodology and reinforces the value of rigorous clinical investigation in evaluating nutritional health interventions.
In this episode of the GMJ Podcast — the official podcast of the Georgian Medical Journal, we examine recent scientific evidence exploring whether daily multivitamin supplementation may influence biological ageing.
The discussion is based on findings published in Nature Medicine from the COSMOS randomized clinical trial. Researchers analysed the effects of multivitamin–multimineral supplementation and cocoa extract on epigenetic ageing markers among older adults.
Epigenetic clocks, which estimate biological age using DNA methylation patterns, were used to evaluate potential biological ageing processes. The results indicated that participants who received daily multivitamin supplementation demonstrated a modest but statistically significant slowing of several second-generation epigenetic ageing markers during the two-year intervention period.
In contrast, cocoa extract supplementation did not show measurable effects on the analysed epigenetic ageing indicators.
Although the observed effect was relatively small, the findings contribute to the growing scientific discussion on whether nutritional interventions may influence biological ageing and long-term health outcomes.
Reference
Li S et al. Effects of daily multivitamin–multimineral and cocoa extract supplementation on epigenetic aging clocks in the COSMOS randomized clinical trial. Nature Medicine. 2026. doi:10.1038/s41591-026-04239-3